3-Feb-2026 7:44 AM CST - Yahoo Finance Viatris Appoints Matthew J. Maletta as Chief Legal Officer Viatris Inc. (Nasdaq: VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO,
22-Jan-2026 11:12 AM CST - Yahoo Finance Viatris Earnings Preview: What to Expect Viatris is set to report its fourth-quarter earnings soon, with analysts forecasting a slight decline in profits.
6-Jan-2026 12:59 PM CST - Yahoo Finance Viatris (VTRS) Upgraded to Buy: What Does It Mean for the Stock? Viatris (VTRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2-Jan-2026 9:14 AM CST - Yahoo Finance Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the company's global pipeline.
22-Dec-2025 5:48 AM CST - Seeking Alpha Viatris: Looks Cheap, But Faces Continued Contraction Viatris faces revenue declines, execution issues, and high debt post-merger. Click here to read my latest analysis of VTRS stock.
19-Dec-2025 10:54 PM CST - Yahoo Finance Is Viatris' Shift Into Complex Therapies Altering The Investment Case For VTRS? Earlier this week, Viatris announced four pipeline milestones, including US FDA approval of its generic version of Sandostatin LAR Depot and regulatory progress on a low-dose contraceptive patch, an ophthalmology candidate for neurotrophic keratopathy,
18-Dec-2025 6:40 AM CST - Yahoo Finance Viatris Provides Pipeline Update on Four Regulatory Milestones Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline:
Latest VTRS Trades by Congress Members
18-NOV-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
3-Feb-2026 7:44 AM CST - Yahoo Finance Viatris Appoints Matthew J. Maletta as Chief Legal Officer Viatris Inc. (Nasdaq: VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO,
22-Jan-2026 11:12 AM CST - Yahoo Finance Viatris Earnings Preview: What to Expect Viatris is set to report its fourth-quarter earnings soon, with analysts forecasting a slight decline in profits.
6-Jan-2026 12:59 PM CST - Yahoo Finance Viatris (VTRS) Upgraded to Buy: What Does It Mean for the Stock? Viatris (VTRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2-Jan-2026 9:14 AM CST - Yahoo Finance Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the company's global pipeline.
22-Dec-2025 5:48 AM CST - Seeking Alpha Viatris: Looks Cheap, But Faces Continued Contraction Viatris faces revenue declines, execution issues, and high debt post-merger. Click here to read my latest analysis of VTRS stock.
19-Dec-2025 10:54 PM CST - Yahoo Finance Is Viatris' Shift Into Complex Therapies Altering The Investment Case For VTRS? Earlier this week, Viatris announced four pipeline milestones, including US FDA approval of its generic version of Sandostatin LAR Depot and regulatory progress on a low-dose contraceptive patch, an ophthalmology candidate for neurotrophic keratopathy,
18-Dec-2025 6:40 AM CST - Yahoo Finance Viatris Provides Pipeline Update on Four Regulatory Milestones Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline:
